Literature DB >> 23145875

Voltage-driven Ca(2+) binding at the L-type Ca(2+) channel triggers cardiac excitation-contraction coupling prior to Ca(2+) influx.

Liron S Gez1, Yamit Hagalili, Asher Shainberg, Daphne Atlas.   

Abstract

The activation of the ryanodine Ca(2+) release channels (RyR2) by the entry of Ca(2+) through the L-type Ca(2+) channels (Cav1.2) is believed to be the primary mechanism of excitation-contraction (EC) coupling in cardiac cells. This proposed mechanism of Ca(2+)-induced Ca(2+) release (CICR) cannot fully account for the lack of a termination signal for this positive feedback process. Using Cav1.2 channel mutants, we demonstrate that the Ca(2+)-impermeable α(1)1.2/L775P/T1066Y mutant introduced through lentiviral infection into neonate cardiomyocytes triggers Ca(2+) transients in a manner independent of Ca(2+) influx. In contrast, the α(1)1.2/L775P/T1066Y/4A mutant, in which the Ca(2+)-binding site of the channel was destroyed, supports neither the spontaneous nor the electrically evoked contractions. Ca(2+) bound at the channel selectivity filter appears to initiate a signal that is conveyed directly from the channel pore to RyR2, triggering contraction of cardiomyocytes prior to Ca(2+) influx. Thus, RyR2 is activated in response to a conformational change in the L-type channel during membrane depolarization and not through interaction with Ca(2+) ions diffusing in the junctional gap space. Accordingly, termination of the RyR2 activity is achieved when the signal stops upon the return of the L-channel to the resting state. We propose a new model in which the physical link between Cav1.2 and RyR2 allows propagation of a conformational change induced at the open pore of the channel to directly activate RyR2. These results highlight Cav1.2 as a signaling protein and provide a mechanism for terminating the release of Ca(2+) from RyR2 through protein-protein interactions. In this model, the L-type channel is a master regulator of both initiation and termination of EC coupling in neonate cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23145875     DOI: 10.1021/bi301124a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  β-Subunit of the voltage-gated Ca2+ channel Cav1.2 drives signaling to the nucleus via H-Ras.

Authors:  Evrim Servili; Michael Trus; Daphne Maayan; Daphne Atlas
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-27       Impact factor: 11.205

Review 2.  Cardiac T-Tubule Microanatomy and Function.

Authors:  TingTing Hong; Robin M Shaw
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

3.  Calcium Channel Splice Variants and Their Effects in Brain and Cardiovascular Function.

Authors:  Sean Qing Zhang Yeow; Kelvin Wei Zhern Loh; Tuck Wah Soong
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.

Authors:  Alain van Mil; Geerthe Margriet Balk; Klaus Neef; Jan Willem Buikema; Folkert W Asselbergs; Sean M Wu; Pieter A Doevendans; Joost P G Sluijter
Journal:  Cardiovasc Res       Date:  2018-12-01       Impact factor: 10.787

Review 5.  The Mechanics and Thermodynamics of Tubule Formation in Biological Membranes.

Authors:  Arijit Mahapatra; Can Uysalel; Padmini Rangamani
Journal:  J Membr Biol       Date:  2021-01-19       Impact factor: 2.426

Review 6.  Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges.

Authors:  Elvira Immacolata Parrotta; Valeria Lucchino; Luana Scaramuzzino; Stefania Scalise; Giovanni Cuda
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

7.  Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia.

Authors:  TingTing Hong; Huanghe Yang; Shan-Shan Zhang; Hee Cheol Cho; Mariya Kalashnikova; Baiming Sun; Hao Zhang; Anamika Bhargava; Michael Grabe; Jeffrey Olgin; Julia Gorelik; Eduardo Marbán; Lily Y Jan; Robin M Shaw
Journal:  Nat Med       Date:  2014-05-18       Impact factor: 53.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.